The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cardiopulmonary exercise testing of patients with metastatic castrate-resistant prostate cancer as screening for vigorous exercise medicine prescription.
 
Robert Usher Newton
No Relationships to Disclose
 
Nicolas H. Hart
Research Funding - GenesisCare (Inst); Ipsen Pharmaceutical Pty Ltd; Pernix Pty Ltd (Inst)
 
Stacey A. Kenfield
Leadership - Fellow Health Partners
Stock and Other Ownership Interests - Fellow Health Partners
Consulting or Advisory Role - Fellow Health Partners
Research Funding - GenomeDx
 
Daniel Abido Galvao
No Relationships to Disclose
 
Kerry S. Courneya
No Relationships to Disclose
 
Charles M Ryan
No Relationships to Disclose
 
June M. Chan
Employment - Adela (I); GRAIL (I); Myriad Genetics (I)
Stock and Other Ownership Interests - GRAIL (I)
Research Funding - Adela (I); GenomeDx (Inst); Genomic Health (Inst); GRAIL (I); Myriad Genetics (Inst)
Travel, Accommodations, Expenses - GRAIL (I); Myriad Genetics (I)
 
James W.F. Catto
No Relationships to Disclose
 
Kerri M. Winters-Stone
Consulting or Advisory Role - Bayer
 
Mieke Van Hemelrijck
No Relationships to Disclose
 
Harriet Wylie
No Relationships to Disclose
 
Moritz Schumann
No Relationships to Disclose
 
Tina Skinner
No Relationships to Disclose
 
Stephan Praet
No Relationships to Disclose
 
Fred Saad
Honoraria - Abbvie; Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bayer; BMS; Janssen Oncology; Knight Therapeutics; Merck; Myovant Sciences; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Abbvie; Advanced Accelerator Applications; Astellas Pharma; AstraZeneca/MedImmune; Bayer; Janssen Oncology; Knight Therapeutics; Myovant Sciences; Novartis; Pfizer; Sanofi
Research Funding - Advanced Accelerator Applications (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)